Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection
NCT04458519
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
23
Enrollment
OTHER
Sponsor class
Conditions
COVID-19 Infection
Interventions
OTHER:
Probiorinse
OTHER:
Saline solution
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)